Medical News

RSS

Five point challenge to all political parties, setting out how to improve the NHS

A five point challenge to all political parties, setting out how to improve the NHS, is published today (Tuesday 8 March 2005) by the British Medical Association. "A vote to improve health" takes the form of a doctors' manifesto for the forthcoming general election.

7 Mar 2005

Aspirin does not prevent first heart attacks or death from cardiovascular causes in women

The Women's Health Study is the first large clinical trial to study the use of low-dose aspirin to prevent heart attack and stroke in women.

7 Mar 2005

Cancer agents in Chinese Heinz foods

US food giant Heinz is recalling some of their chilli sauces, chilli oils and other products in China due to a suspion they contain the cancer-causing red dye, Sudan-I, already at the centre of a European health scare.

7 Mar 2005

Serum sodium level is a major predictor of a poor prognosis for heart failure patients

Research presented today at the American College of Cardiology's Scientific Sessions in Orlando pinpoints a major marker of a poor prognosis for heart failure, hyponatremia, or a lower than normal concentration of serum or blood sodium.

7 Mar 2005

Unemployment, poverty and housing unaffordability correlated with a risk of mental illness

Does having a low socioeconomic status (SES) lead to depression or does depression lead a person into poverty? According to a study that examined a database of 34,000 patients with two or more psychiatric hospitalizations in Massachusetts during 1994-2000, unemployment, poverty and housing unaffordability were correlated with a risk of mental illness.

7 Mar 2005

Two chemicals boost immune cells' ability to fight HIV without gene therapy

A UCLA AIDS Institute study has discovered that two chemical compounds may help the immune systems of HIV-infected persons fight the disease without invasive gene therapy.

7 Mar 2005

Battle in the Senate over FDA

In the congressional battle over the safety of America's prescription drugs, two University of Washington experts with opposing views have been enlisted into the fray.

7 Mar 2005

Thalidomide may have a new lease of life as a cancer treatment

The drug thalidomide may have a new lease of life as a cancer treatment. A small study published in Gut suggests that it slows down the weight loss and wasting associated with advanced disease in patients with pancreatic cancer.

7 Mar 2005

Diabetic patients run three times the risk of developing liver cancer

The researchers trawled a surveillance database used for patients in receipt of Medicare funding for health care, to identify patients aged 65 and older, who had been diagnosed with liver cancer.

7 Mar 2005

Risky injection behaviors are established at the onset of injection drug use

The circumstances surrounding the first injection experience of young injection drug users are significantly linked to future injection behavior, according to a new study from researchers at the Johns Hopkins Bloomberg School of Public Health and other institutions.

7 Mar 2005

A weighty issue: can your eating habits make you infertile?

The societal pressures on women to be attractive, successful, and thin are stronger than ever. The desirable woman portrayed in the media is much thinner than the average woman. Popular slogans such as "thin is in" and "you can never be too rich or too thin" have equated thinness with happiness. The result is that for the first time in history, being attractive means being thin.

7 Mar 2005

American teenagers are in a calcium crisis

American teenagers are in a calcium crisis, the milk and milk products they need to help form healthy bone is often missing from their diet; about 15 percent of adult height is added at this time and half of all bone is formed March, National Nutrition Month®, the time when health professionals encourage all of us to look at what we eat and make informed food choices, is even more important for kids and teens who are still growing.

7 Mar 2005

Stent trial fails to meet endpoints

Angiotech Pharmaceuticals has announced that results from the REALITY Trial, a head-to-head trial sponsored by Cordis Corporation, comparing the JNJ CYPHER® stent and the TAXUS® stent, were presented at the American College of Cardiology Annual Scientific Session. The trial failed to meet its primary endpoint.

7 Mar 2005

Study looks at the ability of some monkey species to resist developing AIDS

The Tulane National Primate Research Center received a five-year grant of more than $2 million from the National Institute of Allergy and Infectious Diseases to study the ability of some monkey species to resist developing AIDS.

7 Mar 2005

Children should not operate motorbikes until they are old enough to obtain a driver's license

The use of motorbikes among children and adolescents is dangerous, on the rise and leading to a greater number of injuries, according to a new Cincinnati Children's Hospital Medical Center study.

7 Mar 2005

Underhand methods used to challenge secondhand smoke's link to infant death risk

The link between secondhand smoke and sudden infant death has been discredited in the last few years in scientific articles paid for and influenced by cigarette manufacturers, according to a new study of once-secret industry documents.

7 Mar 2005

Insulin levels linked to Alzheimer's disease

Insulin and its related proteins are produced in the brain, and according to researchers from Rhode Island Hospital and Brown Medical School, reduced levels of this combination can be linked to Alzheimer's disease. The findings are reported in the March issue of the Journal of Alzheimer's Disease.

7 Mar 2005

Canadians alerted to the presence of acrylamide in some foods

In 2002, Health Canada alerted Canadians to the presence of acrylamide in some foods, following reports by scientists in Sweden. Since then, Health Canada scientists have participated in international research efforts aimed at understanding how acrylamide is formed in foods and the health implications.

7 Mar 2005

ViroLogic and AstraZeneca to conduct Iressa biomarker study

ViroLogic announced today that it had entered into an agreement with AstraZeneca to conduct a cancer biomarker study with application to Iressa, AstraZeneca's selective epidermal growth factor receptor kinase inhibitor.

7 Mar 2005

David Lee, cancer cure director gets 10 year disqualification

A director of a company who used fear tactics and misleading advertising to sell vulnerable elderly people a 'cure' for prostate cancer has been disqualified from acting as a company director for 10 years following a DTI investigation.

7 Mar 2005